Patents by Inventor Jeffrey Wayne Munos

Jeffrey Wayne Munos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED ANTIBODIES
    Publication number: 20230203191
    Abstract: Provided herein, inter alia, are engineered antibodies or antigen-binding fragments thereof that exhibit one or more improved properties relating to manufacturability, thermostability, and/or protease resistance as well as methods for making and using the same.
    Type: Application
    Filed: March 30, 2021
    Publication date: June 29, 2023
    Inventors: David A. ESTELL, Amy Deming LIU, Michael C. MILLER, Jeffrey Wayne MUNOS, Jonathan David PETERSON
  • ENGINEERED ANTIBODIES
    Publication number: 20220169706
    Abstract: Disclosed herein, inter alia, are cleavage-resistant antibodies and antibody-producing host cells as well as methods for making, using, and improving secretion of the same.
    Type: Application
    Filed: March 30, 2020
    Publication date: June 2, 2022
    Inventors: Jimmy CHAN, David A. ESTELL, Jeffrey Wayne MUNOS, Michael C. MILLER, Igor NIKOLAEV
  • PROTEASE VARIANTS AND USES THEREOF
    Publication number: 20210292728
    Abstract: Disclosed herein is one or more subtilisin variant useful for cleaning applications and in methods of cleaning. One embodiment is directed to one or more subtilisin variant, including one or more Bacillus sp. subtilisin polypeptide variant, and one or more cleaning composition comprising one or more such variant.
    Type: Application
    Filed: March 30, 2021
    Publication date: September 23, 2021
    Inventors: LILIA MARIA BABE, VIKTOR YURYEVICH ALEKSEYEV, NEELAM S. AMIN, JOSHUA ROY BASLER, DAVID A. ESTELL, VICTORIA HUANG, DAVID MARQUEZ, JEFFREY WAYNE MUNOS, REI OTSUKA, GEETHA VEERAMUTHU, DAVID EDWARD WILDES, MICHELLE JACKSON, EUAN JOHN MAGENNIS, EVA MARIA PEREZ-PRAT VINUESA, PHILIP F. SOUTER, DAVID JOHN TARBIT
  • Altered host cell pathway for improved ethanol production
    Patent number: 10428354
    Abstract: A recombinant yeast cell, fermentation compositions, and methods of use thereof are provided. The recombinant yeast cell includes at least one heterologous nucleic acid encoding one or more polypeptide having phosphoketolase activity; phosphotransacetylase activity; and/or acetylating acetaldehyde dehydrogenase activity, wherein the cell does not include a heterologous modified xylose reductase gene, and wherein the cell is capable of increased biochemical end product production in a fermentation process when compared to a parent yeast cell.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: October 1, 2019
    Assignee: DANISCO US INC
    Inventors: Andrei Miasnikov, Jeffrey Wayne Munos
  • PROTEASE VARIANTS AND USES THEREOF
    Publication number: 20190194636
    Abstract: Disclosed herein is one or more subtilisin variant useful for cleaning applications and in methods of cleaning. One embodiment is directed to one or more subtilisin variant, including one or more Bacillus sp. subtilisin polypeptide variant, and one or more cleaning composition comprising one or more such variant.
    Type: Application
    Filed: May 3, 2017
    Publication date: June 27, 2019
    Inventors: Lilia Maria Babe, Joshua Roy Basler, David A. Estell, Viktor Yuryevich Alekseyev, David Edward Wildes, Jeffrey Wayne Munos, Neelam S. Amin, David Marquez, Victoria Huang, Geetha Veeramuthu, Rei Otsuka, Philip F. Souter, David John Tarbit, Michelle Jackson, Eva Maria Perez-Prat Vinuesa, Euan John Magennis
  • ALTERED HOST CELL PATHWAY FOR IMPROVED ETHANOL PRODUCTION
    Publication number: 20190127765
    Abstract: A recombinant yeast cell, fermentation compositions, and methods of use thereof are provided. The recombinant yeast cell includes at least one heterologous nucleic acid encoding one or more polypeptide having phosphoketolase activity; phosphotransacetylase activity; and/or acetylating acetaldehyde dehydrogenase activity, wherein the cell does not include a heterologous modified xylose reductase gene, and wherein the cell is capable of increased biochemical end product production in a fermentation process when compared to a parent yeast cell.
    Type: Application
    Filed: January 10, 2019
    Publication date: May 2, 2019
    Inventors: Andrei Miasnikov, Jeffrey Wayne Munos